Mainstay Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,846
| Closed | -$274K | – | 117 |
|
|
2020
Q3 | $274K | Sell |
2,846
-60
| -2% | -$5.78K | 0.07% | 99 |
|
|
2020
Q2 | $354K | Buy |
2,906
+260
| +10% | +$31.7K | 0.1% | 82 |
|
|
2020
Q1 | $228K | Buy |
2,646
+435
| +20% | +$37.5K | 0.07% | 83 |
|
|
2019
Q4 | $238K | Sell |
2,211
-965
| -30% | -$104K | 0.05% | 94 |
|
|
2019
Q3 | $288K | Sell |
3,176
-22
| -0.7% | -$2K | 0.16% | 84 |
|
|
2019
Q2 | $270K | Buy |
3,198
+768
| +32% | +$64.8K | 0.14% | 83 |
|
|
2019
Q1 | $213K | Sell |
2,430
-769
| -24% | -$67.4K | 0.16% | 81 |
|
|
2018
Q4 | $222K | Sell |
3,199
-1,011
| -24% | -$70.2K | 0.16% | 80 |
|
|
2018
Q3 | $518K | Buy |
4,210
+28
| +0.7% | +$3.45K | 0.33% | 67 |
|
|
2018
Q2 | $411K | Buy |
4,182
+37
| +0.9% | +$3.64K | 0.32% | 63 |
|
|
2018
Q1 | $343K | Sell |
4,145
-602
| -13% | -$49.8K | 0.26% | 70 |
|
|
2017
Q4 | $368K | Buy |
+4,747
| New | +$368K | 0.31% | 65 |
|